...
机译:多晶核霉菌衍生的抑制细胞通过负调节第2组先天淋巴细胞来衰减过敏气道炎症
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
The First Affiliated Hospital of Sun Yat‐sen UniversityGuangzhou China;
Department of Obstetrics and GynaecologyGuangzhou Women and Children's Medical CentreGuangzhou China;
Department of Obstetrics and GynaecologyGuangzhou Women and Children's Medical CentreGuangzhou China;
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
Institute of Human Virology Zhongshan School of MedicineSun Yat‐sen UniversityGuangzhou China;
allergic airway inflammation; group 2 innate lymphoid cells; polymorphonuclear myeloid‐derived suppressor cells;
机译:多晶核霉菌衍生的抑制细胞通过负调节第2组先天淋巴细胞来衰减过敏气道炎症
机译:来自人间充质基质细胞的小细胞外囊泡通过递送miR-146a-5p,预防第2组先天淋巴细胞 - 显性过敏气道炎症
机译:MiR-146A模仿通过受影响的第2组先天淋巴细胞在卵磷酸突诱导的哮喘小鼠模型中衰减过敏气道炎症
机译:用Janus合成纳米颗粒抗体耗尽骨髓来源的抑制细胞作为癌症免疫治疗。
机译:晚期糖基化终产物的受体通过第2组先天淋巴样细胞介导过敏性气道炎症。
机译:多形核髓样抑制细胞通过负调控2组先天淋巴样细胞来减轻过敏性气道炎症
机译:多孔核霉菌衍生的抑制细胞通过对2族先天淋巴细胞产生负面调节2型先天淋巴细胞衰减过敏气道炎症